Samuel Whiting's Insider Trades & SAST Disclosures
Samuel Whiting's most recent trade in Tempest Therapeutics Inc was a trade of 270,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Samuel Whiting.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 270,000 | 270,000 | - | - | Employee Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.13 per share. | 02 Jul 2024 | 4,672 | 9,573 | - | 2.1 | 9,951 | Common Stock |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 69,700 | 69,700 | - | - | Employee Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 55,680 | 55,680 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.80 per share. | 06 Jan 2022 | 1,700 | 1,901 | - | 4.8 | 8,168 | Common Stock |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 29,000 | 29,000 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 540,231 | 540,231 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 61,945 | 61,945 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 3,018 | 3,018 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 201 | 201 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges